WM, H., W, S., FHM, M., CM, H., S, v. E., GD, V., . . . LAA, B. (2020). Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas. Endocrine pathology, 31(2), 108. https://doi.org/10.1007/s12022-020-09611-8
Chicago Style (17th ed.) CitationWM, Hackeng, et al. "Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas." Endocrine Pathology 31, no. 2 (2020): 108. https://doi.org/10.1007/s12022-020-09611-8.
MLA (9th ed.) CitationWM, Hackeng, et al. "Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas." Endocrine Pathology, vol. 31, no. 2, 2020, p. 108, https://doi.org/10.1007/s12022-020-09611-8.